| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |